Drugs / LTM1201L
last change Dec 2019 re-read 3 minutes ago

LTM1201L

Developed for
obstructive sleep apnea syndrome

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 1/2 NCT03640052 Comparator Oct 2018 → Sep 2019 obstructive sleep apnea syndrome Brigham and Women's Hospital Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LTM1201L ClinicalTrials.gov intervention name — accepted as the source's own label NCT03640052 ↗